Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
AstraZeneca
Mallinckrodt
Colorcon
McKesson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Litigation Details for Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. (N.D. Ill. 2008)

See Plans and Pricing

« Back to Dashboard

Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. (N.D. Ill. 2008)

Docket   Start Trial Date Filed 2008-02-29
Court District Court, N.D. Illinois Date Terminated 2008-11-12
Cause 35:271 Patent Infringement Assigned To John Francis Grady
Jury Demand None Referred To
Parties ABBOTT LABORATORIES; LABORATORIES FOURNIER S.A.; TEVA PHARMACEUTICALS USA, INC.
Patents 4,895,726; 5,145,684; 6,074,670; 6,277,405; 6,375,986; 6,511,678; 6,528,090; 6,589,552; 6,652,881; 6,713,086; 6,720,004; 7,037,529; 7,041,319; 7,276,249; 7,320,802
Attorneys Alice Ching-Ting Su; Anne M. Rucker; Bruce Michael Gagala; Chad J Peterman; Douglas Alan Robinson; Glenn J. Pfadenhauer; James F. Hurst; Kendra P. Robins; Kevin Hardy; Laura K McNally; Lynn Hagman Murray; Marion D. Hefner; Peter Herebert Domer; Peter J. Meyer; Stephanie S McCallum; William F Cavanaugh , Jr.
Firms Harness Dickey and Pierce; Kirkland and Ellis LLP; Leydig, Voit & Mayer Ltd.; Leydig, Voit & Mayer, Ltd.; Loeb & Loeb LLP; Patterson Belknap Webb & Tyler LLP; Shook, Hardy & Bacon LLP; Steptoe and Johnson LLP; Williams & Connolly LLP; Winston and Strawn
Link to Docket External link to docket
Small Molecule Drugs cited in Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Abbott Laboratories v. Teva Pharmaceuticals USA, Inc. (N.D. Ill. 2008)

Date Filed Document No. Description Snippet Link To Document
2008-02-29 1 complaint owner by assignment of U.S. Patent Nos. (a) 6,277,405 (“the ‘405 patent”)(attached hereto as Exhibit…each of the Patents-in-Suit patent remain valid and enforceable, and each of the Patents-in-Suit is infringed… Complaint is an action for patent infringement arising under the patent laws of the United States, Title… (“the ‘529 patent”) (attached hereto as Exhibit 2), and (c) 7,041,319 (“the ‘319 patent”) (attached …‘405, ‘529, and ‘319 patents are collectively referred to herein as the “Patents-in-Suit.” External link to document
2008-03-03 11 Patent/Trademark/Copyright report PATENTEE US 6,277,405 B1 8/21/2007 … MAILED patent report to Patent Trademark Office, Alexandria, VA. (td, ) (Entered: 03/03/2008) … Inc. PATENT NO. DATE OF PATENT …Pleading PATENT NO. DATE OF PATENT …(6/90) TO: COMMISSIONER OF PATENTS AND TRADEMARKS External link to document
2008-03-31 21 memorandum in support of motion was also charged with infringing U.S. Patent 4,895,726, a patent which had been the subject of a prior… lists eight patents for TRICOR®, namely, U.S. Patent Nos. 6,277,405 (“the ‘405 patent”) (EX. 5), Case…the ‘529 patent”) (Ex. 6), 7,041,319 (“the ‘319 patent”) (Ex. 7), 5,145,684 (“the ‘684 patent”) (Ex. 8…six of the patents-in-suit in both cases. 1. The Patents-In-Suit in Illinois The patents-in-suit in … 8), 7,276,249 (“the ‘249 patent”) (Ex. 9), and 7,320,802 (“the ‘802 patent”) (Ex. lO). By this listing External link to document
2008-03-31 22 declaration #39;529 patent") U.S. Patent No. 7,041,319 ("the '319 patent") U.S. Patent No. 5,145,684…#39;684 patent") U.S. Patent No. 7,276,249 ("the '249 patent") U.S. Patent No. 7,320,802…No. 021-656 U.S. Patent No. 6,277,405 ("the '405 patent") U.S. Patent No. 7,037,529 ("…,320,802 ("the '802 patent") Teva's Answer (D.l. No. 10), ELAN PHARMA INTERNATIONAL… 12 November 2008 1:08-cv-01243 830 Patent None District Court, N.D. Illinois External link to document
2008-04-22 31 memorandum in opposition to motion .S. Patent Nos. 5.145,684 ("the '684 patent"); 7,276,249 ("the '249 patent"…Composition Having High Bioavailability Elan Patents 5,145,684 G. Liversidge .lan. 25, 1991 Elan A. Rosenstein…FLI. These patents are not in the same patent family as the Starnmeeth Patents. These patents do not have… the patents asserted here and in New Jersey. The patents in this action differ from the patents in the… in patents and requires infringement and validity analyses to be done on a patent claim by patent claim External link to document
2008-02-29 8 other brought for infringement of United States Patent Nos. 6,277,405, 7,037,529 and 7,041,319. The inventors … NOTICE of Claim Involving Patents Pursuant to Local Rule 3.4 by Abbott Laboratories, Laboratories…NOTICE OF CLAIM INVOLVING PATENTS PURSUANT TO LOCAL RULE 3.4 Pursuant…the Court that they have filed a Complaint for patent infringement. Plaintiffs in this action are Abbott… 12 November 2008 1:08-cv-01243 830 Patent None District Court, N.D. Illinois External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
Johnson and Johnson
Baxter
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.